SuperCult® Human Endothelial Cell Growth Medium Kit-2MV

  • Specification
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CM-1366L
Description
SuperCult® Human Endothelial Cell Growth Medium Kit-2MV: Coronary and Iliac artery, human microvascular endothelial cells, contains 5% FBS and VEGF for rapid proliferation. Does not contain BBE.

Media products are supplied in several formats:

Basal Medium - contains no growth factors cytokines, or supplements
Supplement Kits - growth factors, cytokines, and supplements
Medium Kit - basal medium and Supplement Kit packaged together
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Verteporfin combined with ROCK inhibitor promotes the restoration of corneal endothelial cell dysfunction in rats

Biochemical Pharmacology | DOI | Paper |

Background

Corneal endothelial cell (CEC) dysfunction causes corneal edema and blindness, and endothelial-to-mesenchymal transition (EndMT) limits regenerative drug therapy. This study asked whether verteporfin (VP), a YAP inhibitor, could complement the ROCK inhibitor Y-27632. Using a rat corneal endothelial injury model and TGF-β1-induced EndMT in human CECs, the authors show YAP rises after injury and tracks with EndMT. A 1:1 VP/Y-27632 combination reversed EndMT, promoted proliferation, restored adhesion proteins and corneal transparency, offering a new treatment strategy.

Key Findings

YAP expression was higher in fetal than adult human CECs, declined with age in rat CECs, and negatively correlated with functional markers AQP1 and ATP1A1; injury raised YAP 3.51-fold. Verteporfin (0.2 µM) reversed TGF-β1-induced EndMT in B4G12 human CECs, downregulating ACTA2, VIM, SNAI1 and CDH2 while upregulating TJP1 and ATP1A1, but it inhibited CEC proliferation. Y-27632 promoted proliferation and wound healing yet only partially reduced α-SMA, leaving vimentin unchanged. Combining VP with Y-27632 at a 1:1 ratio (0.2 µM each) gave the highest proliferation and strongest EndMT inhibition, suppressing TGF-β downstream HMGA2, SNAI1 and FOXC2. In injured rat corneas, the combination reduced corneal thickness and opacity, increased ZO1 and EDU incorporation, and lowered α-SMA and vimentin by day 14, restoring endothelial function and morphology.

Contribution

Creative Bioarray supplied the SuperCult® human endothelial cell growth medium used to culture the B4G12 human corneal endothelial cell line throughout the in vitro work, providing the standardized culture system that supported TGF-β1-induced EndMT modeling, drug-combination screening, proliferation and migration assays, and mechanistic analyses.

The restoration effect of VP combined with Y-27632 on the injury of CECs in rats.
Fig. 1. The restoration effect of VP combined with Y-27632 on the injury of CECs in rats.

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products